The Irish Independent’s View: For Ireland to have a two-tier system for cancer treatment in 2025 is unacceptable

Ireland has one of the lowest rates of availability for newly licensed cancer medicines among western European countries. The finding of an analysis by the European Federation of Pharmaceutical Industries and Associations is supported by other research in the area.